IL‐35: A potential therapeutic target for controlling hepatitis B virus infection

E-ISSN： 1751-2980|16|1|1-6

ISSN： 1751-2972

Source： Journal of Digestive Diseases, Vol.16, Iss.1, 2015-01, pp. : 1-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

New therapeutic strategies in the treatment of hepatitis B virus infection

By Torresi J. Locarnini S.A.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 3, 1999-03 ,pp. : 289-305

Informa Healthcare

Access to resources Recommend Favorite

Pathogenesis of hepatitis B virus infection

By Zhang Xiaodong Zhang Weiying Ye Lihong

Future Virology, Vol. 1, Iss. 5, 2006-09 ,pp. : 637-647

Future Medicine

Access to resources Recommend Favorite

IL-35: a potential target for the treatment of atherosclerosis

By Huang Ying Lin Ying-Zhong Shi Ying Ji Qing-Wei

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 10, 2013-10 ,pp. : 793-795

Govi-Verlag

Access to resources Recommend Favorite

Emerging Therapeutic Strategies for Hepatitis C Virus Infection

Current Molecular Pharmacology, Vol. 1, Iss. 2, 2008-01 ,pp. : 130-150

Bentham Science Publishers

Access to resources Recommend Favorite

Advances and Challenges in the Development of Therapeutic DNA Vaccines Against Hepatitis B Virus Infection

Current Gene Therapy, Vol. 14, Iss. 3, 2014-06 ,pp. : 149-160

Bentham Science Publishers

Access to resources Recommend Favorite